Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2022-02-14 1:39 pm Purchase | 13G | GRITSTONE BIO INC GRTS | EcoR1 Capital LLC | 6,319,232 9.3% | 1,384,300 (+28.05%) | View |
2022-02-14 1:38 pm Sale | 13G | ARS PHARMACEUTICALS, INC SPRY | EcoR1 Capital LLC | 1,060,010 3% | -1,473,625 (-58.16%) | View |
2022-02-14 1:38 pm Sale | 13G | INFINITY PHARMACEUTICALS INC C INFI | EcoR1 Capital LLC | 0 0% | -4,368,500 (Position Closed) | View |
2022-02-14 1:37 pm Sale | 13G | AC IMMUNE SA SHS ACIU | EcoR1 Capital LLC | 749,585 0.9% | -3,952,575 (-84.06%) | View |
2022-02-14 12:49 pm Purchase | 13G | XENCOR INC XNCR | EcoR1 Capital LLC | 4,906,106 8.4% | 359,034 (+7.90%) | View |
2022-02-02 7:52 pm Purchase | 13G | GALAPAGOS NV SPONSORED ADR GLPG | EcoR1 Capital LLC | 3,407,246 5.2% | 3,407,246 (New Position) | View |
2022-01-31 4:39 pm Purchase | 13G | KURA ONCOLOGY INC KURA | EcoR1 Capital LLC | 4,543,447 6.8% | 2,770,410 (+156.25%) | View |
2022-01-13 6:45 pm Purchase | 13D | PROTHENA CORP PLC SHS PRTA | EcoR1 Capital LLC | 11,584,280 24.9% | 2,157,640 (+22.89%) | View |
2021-12-10 5:24 pm Sale | 13G | ODONATE THERAPEUTICS INC ODT | EcoR1 Capital LLC | 0 0% | -5,701,669 (Position Closed) | View |
2021-12-10 5:08 pm Purchase | 13G | ATEA PHARMACEUTICALS INC AVIR | EcoR1 Capital LLC | 5,376,134 6.5% | 5,376,134 (New Position) | View |
2021-11-18 1:03 pm Purchase | 13G | ODONATE THERAPEUTICS INC ODT | EcoR1 Capital LLC | 5,701,669 14.8% | 2,337,969 (+69.51%) | View |
2021-11-16 12:20 pm Purchase | 13G | 2SEVENTY BIO INC TSVT | EcoR1 Capital LLC | 1,890,663 8.1% | 1,890,663 (New Position) | View |
2021-10-22 4:46 pm Purchase | 13G | VOYAGER THERAPEUTICS INC VYGR | EcoR1 Capital LLC | 3,557,507 9.4% | 3,557,507 (New Position) | View |
2021-10-05 1:03 pm Sale | 13G | CORVUS PHARMACEUTICALS INC CRVS | EcoR1 Capital LLC | 81,077 0.2% | -5,000,000 (-98.40%) | View |
2021-09-23 3:14 pm Purchase | 13G | CORVUS PHARMACEUTICALS INC CRVS | EcoR1 Capital LLC | 5,081,077 12% | 1,501,700 (+41.95%) | View |
2021-07-19 5:23 pm Purchase | 13G | ODONATE THERAPEUTICS INC ODT | EcoR1 Capital LLC | 3,363,700 8.7% | 3,363,700 (New Position) | View |
2021-07-19 5:16 pm Purchase | 13G | ARCUS BIOSCIENCES INC RCUS | EcoR1 Capital LLC | 4,572,047 6.4% | 4,572,047 (New Position) | View |
2021-07-12 1:26 pm Purchase | 13G | ALECTOR INC ALEC | EcoR1 Capital LLC | 4,742,634 6% | 4,742,634 (New Position) | View |
2021-05-17 5:16 pm Purchase | 13G | SHATTUCK LABS INC STTK | EcoR1 Capital LLC | 3,295,088 7.9% | 3,295,088 (New Position) | View |
2021-05-11 4:08 pm Purchase | 13D | ANAPTYSBIO INC ANAB | EcoR1 Capital LLC | 7,520,424 27.5% | 368,800 (+5.16%) | View |